{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:08:01Z","timestamp":1784092081634,"version":"3.55.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The clinical benefits of percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) are frequently compromised by the occurrence of microvascular obstruction (MVO). The C-reactive protein-triglyceride glucose index (CTI) is a novel biomarker integrating systemic inflammation and insulin resistance. We aimed to evaluate the association between CTI and MVO, as well as its prognostic value for long-term outcomes in AMI patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study included patients with AMI who underwent successful primary PCI and subsequent cardiac magnetic resonance (CMR). MVO and cardiac function were assessed by CMR. The primary endpoint was the occurrence of MVO, and the secondary endpoint was the incidence of major adverse cardiovascular events (MACE).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 967 patients were ultimately included, comprising 255 with diabetes mellitus and 712 without diabetes; 476 patients developed CMR-defined MVO. Higher baseline CTI levels were significantly and independently associated with an increased risk of MVO (OR\u00a0=\u00a01.33, 95% CI: 1.13\u20131.56, P\u00a0=\u00a00.001). A linear dose-response relationship was observed between CTI and MVO risk (P for overall &amp;lt; 0.05, P for nonlinear &amp;gt; 0.05). During a median follow-up of 43 months, higher CTI levels were associated with an increased risk of long-term MACE in the overall population and the non-diabetic subgroup, whereas this association was attenuated in patients with diabetes mellitus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CTI is independently associated with MVO after PCI in AMI patients and shows modest prognostic value for long-term MACE, particularly in patients without diabetes. As a clinically accessible tool, CTI may facilitate early risk stratification and individualized microvascular protection strategies following PCI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1889147","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:45:04Z","timestamp":1784090704000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of the C-reactive protein-triglyceride glucose index with microvascular obstruction and long-term prognosis in patients with acute myocardial infarction: a CMR-based study"],"prefix":"10.3389","volume":"17","author":[{"given":"Lei","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]},{"name":"National Heart Centre Singapore, Duke - NUS Medical School","place":["Singapore, Singapore"]},{"name":"Department of Cardiology, Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexiang","family":"Zong","sequence":"additional","affiliation":[{"name":"National Heart Centre Singapore, Duke - NUS Medical School","place":["Singapore, Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temilola J.","family":"Oketunbi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingchang","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyuan","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenliang","family":"Che","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wensu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2024.03.408","article-title":"Clinical outcomes associated with various microvascular injury patterns identified by CMR after STEMI","volume":"83","author":"Lechner","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.07.042","article-title":"Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC state-of-the-art review","volume":"78","author":"Del Buono","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx414","article-title":"Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials","volume":"38","author":"de Waha","year":"2017","journal-title":"Eur Heart J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2014.06.012","article-title":"Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: a systematic review and meta-analysis","volume":"7","author":"Hamirani","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cjca.2023.09.020","article-title":"The Canadian Cardiovascular Society classification of acute atherothrombotic myocardial infarction based on stages of tissue injury severity: an expert consensus statement","volume":"40","author":"Kumar","year":"2024","journal-title":"Can J Cardiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000047527.11221.29","article-title":"Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging","volume":"107","author":"Kwong","year":"2003","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.12.037","article-title":"Microvascular obstruction: underlying pathophysiology and clinical diagnosis","volume":"55","author":"Bekkers","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12933-025-03068-x","article-title":"Insulin resistance and coronary microvascular dysfunction: a complex interplay","volume":"25","author":"Magistri","year":"2026","journal-title":"Cardiovasc Diabetol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00603.2021","article-title":"Mechanisms and clinical implications of endothelium-dependent vasomotor dysfunction in coronary microvasculature","volume":"322","author":"Sabe","year":"2022","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12933-023-01846-z","article-title":"Association between the triglyceride-glucose index and the presence and prognosis of coronary microvascular dysfunction in patients with chronic coronary syndrome","volume":"22","author":"Zhang","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.905266","article-title":"A novel inflammation and insulin resistance related indicator to predict the survival of patients with cancer","volume":"13","author":"Ruan","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12933-026-03174-4","article-title":"Associations between the C-reactive protein-triglyceride glucose index and the incidence and progression trajectory of cardiometabolic multimorbidity: a multi-state model study","volume":"25","author":"Yuan","year":"2026","journal-title":"Cardiovasc Diabetol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12933-025-02686-9","article-title":"Association between C-reactive protein-triglyceride glucose index and stroke risk in different glycemic status: insights from the China Health and Retirement Longitudinal Study (CHARLS)","volume":"24","author":"Huo","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12933-025-02876-5","article-title":"Association between the C-reactive protein-triglyceride glucose index and new-onset coronary heart disease among metabolically heterogeneous individuals","volume":"24","author":"Chen","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth\u00a0universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2337\/dc26-S002","article-title":"2. Diagnosis and classification of diabetes: Standards of care in diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.039395","article-title":"Prognostic value of strain by tissue tracking cardiac magnetic resonance in myocardial infarction with nonobstructive coronary arteries","volume":"14","author":"Chen","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2014.05.010","article-title":"Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients","volume":"7","author":"van Kranenburg","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12933-022-01576-8","article-title":"Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study","volume":"21","author":"Wu","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12933-022-01588-4","article-title":"The predictive value of the triglyceride-glucose index for cardiovascular events in patients with coronary chronic total occlusion","volume":"21","author":"Li","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.49.11.1939","article-title":"High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells","volume":"49","author":"Inoguchi","year":"2000","journal-title":"Diabetes"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa009","article-title":"The pathogenic role of coronary microvascular dysfunction in the setting of other cardiac or systemic conditions","volume":"116","author":"Konst","year":"2020","journal-title":"Cardiovasc Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.192399699","article-title":"C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids","volume":"99","author":"Chang","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"B25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.atherosclerosis.2005.01.057","article-title":"C-reactive protein induces VCAM-1 gene expression through NF-kappaB activation in vascular endothelial cells","volume":"185","author":"Kawanami","year":"2006","journal-title":"Atherosclerosis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.114.303215","article-title":"Inflammation, C-reactive protein, and cardiovascular disease: moving past the marker versus mediator debate","volume":"114","author":"Ridker","year":"2014","journal-title":"Circ Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12933-026-03135-x","article-title":"Association between C-reactive protein-triglyceride-glucose index and risk of stroke in different renal function status: a national cohort study","volume":"25","author":"Xian","year":"2026","journal-title":"Cardiovasc Diabetol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12933-025-02848-9","article-title":"C-reactive protein-triglyceride glucose index in evaluating cardiovascular disease and all-cause mortality incidence among individuals across stages 0-3 of cardiovascular-kidney-metabolic syndrome: a nationwide prospective cohort study","volume":"24","author":"Ou","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12933-025-02835-0","article-title":"Association of C-reactive protein-triglyceride glucose index with the incidence and mortality of cardiovascular disease: a retrospective cohort study","volume":"24","author":"Sun","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-022-01236-0","article-title":"Pre-diabetes, diabetes, hyperglycemia, and stroke: bittersweet therapeutic opportunities","volume":"22","author":"Bruno","year":"2022","journal-title":"Curr Neurol Neurosci Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30405-X","article-title":"Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression","volume":"8","author":"van Sloten","year":"2020","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1889147\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:45:13Z","timestamp":1784090713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1889147\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":31,"alternative-id":["10.3389\/fendo.2026.1889147"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1889147","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"article-number":"1889147"}}